In addition, via binding to CCR3, CCL7 overexpression activates the ERK/JNK signaling pathway that converges on the downstream pathways of the MAPK cascade, thereby participating in the epithelial-mesenchymal transition (EMT) process that is sufficient to strengthen cancer metastasis capabilities (Lee et al., 2016). Here, CCR3 is linked to cancer.